STEP-HFpEF-DM — citing documents
Every Institute document that draws on this record.
§5Citing documents
This page records every Institute document that draws on STEP-HFpEF-DM. A trial abstract is a node in the document set rather than a leaf: it is cited by the monographs that use its estimate and by the syntheses that include it, and those citations are listed here so that the flow of an estimate through the document set can be followed in both directions.
§5.1Monograph evidence extracts
Table 7. Monograph evidence extracts that draw on this trial.
| Compound | Indication | Certainty there |
|---|---|---|
| Semaglutide | Heart failure with preserved ejection fraction and obesity | Moderate |
§5.2Evidence syntheses
Table 8. Evidence syntheses that include this trial among their contributing studies.
§5.3Other records in the same programme
Table 9. Other records in the STEP — Semaglutide Treatment Effect in People with obesity.
| Record | Type | Phase | Status |
|---|---|---|---|
| STEP-1 | Published trial | 3 | Reported |
| STEP-2 | Published trial | 3 | Reported |
| STEP-3 | Published trial | 3 | Reported |
| STEP-4 | Published trial | 3 | Reported |
| STEP-5 | Published trial | 3 | Reported |
| STEP-8 | Published trial | 3 | Reported |
| STEP-TEENS | Published trial | 3 | Reported |
| STEP-HFpEF | Published trial | 3 | Reported |
| STEP-1-ADHERENCE | Programme record | 3 | Reported |
| STEP-2-DDI | Programme record | 1 | Reported |
| STEP-3-ELDERLY | Programme record | 3 | Reported |
| STEP-4-RENAL-IMP | Programme record | 1 | Reported |
| STEP-5-PK | Programme record | 1 | Reported |
| STEP-8-RENAL-IMP | Programme record | 1 | Reported |
| STEP-TEENS-HEPATIC-IMP | Programme record | 1 | Reported |
| STEP-HFpEF-HEPATIC-IMP | Programme record | 1 | Reported |
| STEP-HFpEF-DM-BODY-COMP | Programme record | 3 | Reported |
| STEP-1-BIOMARKER | Programme record | 3 | Reported |
| STEP-2-HEPATIC-IMP | Programme record | 1 | Reported |
| STEP-3-OLE | Programme record | 3 | Reported |
| STEP-4-PK | Programme record | 1 | Reported |
| STEP-5-RENAL-IMP | Programme record | 1 | Reported |
| STEP-8-PK | Programme record | 1 | Reported |
| STEP-TEENS-DDI | Programme record | 1 | Reported |
| STEP-HFpEF-DDI | Programme record | 1 | Reported |
| STEP-1-ELDERLY | Programme record | 3 | Reported |
| STEP-2-RENAL-IMP | Programme record | 1 | Reported |
| STEP-3-ADHERENCE | Programme record | 3 | Reported |
| STEP-4-DDI | Programme record | 1 | Reported |
| STEP-5-HEPATIC-IMP | Programme record | 1 | Reported |
| STEP-8-DDI | Programme record | 1 | Reported |
| STEP-TEENS-PK | Programme record | 1 | Reported |
| STEP-1-OLE | Programme record | 3 | Reported |
| STEP-2-PK | Programme record | 1 | Reported |
| STEP-3-BIOMARKER | Programme record | 3 | Reported |
| STEP-4-HEPATIC-IMP | Programme record | 1 | Reported |
| STEP-5-DDI | Programme record | 1 | Reported |
| STEP-8-HEPATIC-IMP | Programme record | 1 | Reported |
| STEP-8-BIOMARKER | Programme record | 3 | Reported |
§5.4Reference
The published report or reports the Institute holds for this trial[1].
References cited on this page
References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.
- Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Møller DV, Shah SJ, Treppendahl MB, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Petrie MC. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. New England Journal of Medicine 2023;389(12):1069–1084. doi:10.1056/NEJMoa2306963 · PMID 37622681
Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.